Home / Indicator library / Biotechnology and Medical Care / OP (4166) overview
OP (4166) stock overview
Valuation, financials, growth, ownership, events, dividends, models and adjusted prices for OP, on one pageOP (4166) snapshot, key figures
OP (4166): where today sits in the past year
Current value against the 2025-07-31 to 2026-07-31 range, built from 229 frozen daily vintages.
Seven-dimension checkup for this ticker →
Valuation river
→Financial quality
→Revenue growth
→Ownership structure
→Events, last 90 days
→Yield river
→Valuation models
→Adjusted-price candles
→4166: common questions
What is 4166's P/E ratio?
4166 traded at a price-to-earnings ratio of 30.93x in the official-source snapshot dated 2026-08-03. That figure is frozen as a point-in-time vintage, so a backtest reading it sees only what was knowable that day.
What is 4166's dividend yield?
4166's cash dividend yield was 0.00% on 2026-08-03. Historical dividend policy and gap-fill records are available on the same page.
How fast is 4166's revenue growing?
4166 reported 68.3% year-on-year monthly revenue growth for 2026-06, from the official monthly revenue filing.
Is 4166's price / earnings high or low right now?
4166's price / earnings is 30.93x, which is below its one-year median of 46.13x and sits at the 29th percentile of the 26.33–78.47x range observed over the last 229 snapshot dates. Each of those dates is a frozen point-in-time vintage, so the range contains no restated or back-filled values.
Other Biotechnology and Medical Care tickers
160 Taiwan-listed tickers sit in this sector. See the full Biotechnology and Medical Care table.